文献速递肺外科

肺叶切除术后不良事件的经济负担:加拿大10家高容量医院的成本分析

Financial Burden of Postoperative Adverse Events Following Lobectomy: Cost Analysis From 10 High-Volume Canadian Hospitals.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

该研究基于加拿大10家医院2017至2022年的肺叶切除术数据,估算术后不良事件的院内成本。研究强调需针对高影响不良事件开展价值导向的质量改进。

要点

  • PAL占肺叶切除术后不良事件发生总数的51%,是成本的最强驱动因素。
  • PAL年均发生率17%,其次为房性心律失常(13%)和肺炎(7.9%)。

核心结论

  • 肺叶切除术后不良事件造成显著经济负担,PAL单独占总成本一半以上。
  • 需针对高影响不良事件开展价值导向的质量改进,需外科医生、医院管理层和政策制定者协同行动。

研究设计与样本

  • 基于加拿大10家医院2017至2022年肺叶切除术数据的前瞻性 national 数据库分析。
  • 年均肺叶切除量1150例(SD=165),44%男性,年龄67岁(SD=10.9),中位住院4天(IQR=4),微创手术占86%。
  • 采用文献衍生的不良事件指数住院成本,参考加拿大健康信息研究所数据库,以2025加元估算年度不良事件成本。

主要发现

  • PAL占不良事件发生总数的51%,房性心律失常13%,肺炎7.9%,再手术5.2%,肺不张3.9%,谵妄3.4%,输血2.8%,呼吸衰竭2.8%,脓胸2.2%,急性肾损伤1.7%,肺栓塞1.2%。
  • PAL年均发生率17%,是成本的最强驱动因素。

临床怎么用

  • 应优先针对PAL等高影响不良事件开展质量改进项目以降低经济负担。
  • 需要外科医生、医院管理层和政策制定者协同行动推进价值导向的质量改进。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Lobectomy remains a cornerstone of curative intent treatment for lung cancer; however, postoperative adverse events (AEs) remain common, harmful, and costly. To support value-based quality improvement (QI) programmes, we sought to estimate the in-hospital costs of AEs following lobectomy and identify which complications are the primary cost drivers. METHODS: Lobectomy data from 10 Canadian hospitals were included (2017-2022). Annual lobectomy volume, demographics, length of stay (LOS), incidence, and severity of AEs were obtained from a prospectively collected national database. Using literature-derived index hospitalization costs of AEs, supported by Canadian Institution of Health Information database, estimates of annual AE costs were obtained (2025 CDN$). RESULTS: Mean annual lobectomy volume 1150 (SD = 165): 44% male, aged 67 years (SD = 10.9), median LOS of 4 days (interquartile range [IQR] = 4), with minimally invasive surgery performed in 86%. Prolonged air leak (PAL) contributed 51% of total AEs occurrences, followed by atrial arrhythmia (13%), pneumonia (7.9%), reoperation (5.2%), atelectasis (3.9%), delirium (3.4%), transfusion (2.8%), respiratory failure (2.8%), empyema (2.2%), acute kidney injury (1.7%), and pulmonary embolism (1.2%), adding over $7.31 million (M) to hospital-level costs. PAL, mean annual incidence of 17%, was the strongest driver of costs. Extrapolated nationally, lobectomy-related AEs are estimated to contribute over $48 million in excess annual costs. CONCLUSIONS: Postoperative AEs following lobectomy impose substantial financial burdens, with PAL alone accounting for more than half of total costs. These findings underscore the need for value-based QI initiatives targeting high-impact AEs, requiring coordinated action among surgeons, hospital leadership, and policymakers.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Jones DG, Anstee C, Yasufuku K, et al. Financial Burden of Postoperative Adverse Events Following Lobectomy: Cost Analysis From 10 High-Volume Canadian Hospitals. Eur J Cardiothorac Surg. 2026. PMID: 41494984. doi:10.1093/ejcts/ezag008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。